Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI-Guided Ultrasound Stimulated Microbubbles with Radiation for Breast Cancer
NCT06633601Phase 1Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jul 2024
- Primary completion
- Mar 2026
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of perflutren lipid microspheres in breast cancer, sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Safety profile of MRI-guided ultrasound stimulated microbubble treatment and radiation at 2 years. Started Jul 2024; status: recruiting.
02
Drugs
perflutren lipid microspheres
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06633601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06633601.